Methamphetamine is a potent central nervous system (CNS) stimulant that is mainly used as a recreational drug and less commonly as a second-line treatment for attention deficit hyperactivity disorder and obesity. Methamphetamine was discovered in 1893 and exists as two enantiomers: levo(-)-methamphetamine and dextro(+)-methamphetamine. It was first synthesized from Ephedrine in 1893 by the Japanese chemist Nagai Nagayoshi. Crystal methamphetamine was first synthesized in 1919 by Japanese chemist Akira Ogata. Methamphetamine properly refers to a specific chemical substance, the racemic free base, which is an equal mixture of levomethamphetamine and dextromethamphetamine in their pure amine forms. Dextromethamphetamine is a stronger CNS stimulant than levomethamphetamine. It is structurally related to Amphetamine, however it crosses the blood-brain barrier more rapidly, due to its relatively high lipid solubility. It produces its effects by increasing levels of the neurotransmitters serotonin, dopamine, and norepinephrine in the brain.
Methamphetamine belongs to the substituted phenethylamine and substituted Amphetamine chemical classes. It is related to the other dimethylphenethylamines as a positional isomer of these compounds, which share the common chemical formula C10H15N.
Methamphetamine is a Schedule II stimulant under the Controlled Substances Act, which means that it has a high potential for abuse and a currently accepted medical use (in FDA-approved products). It is available only through a prescription that cannot be refilled. Today there is only one legal meth product, Desoxyn®. It is currently marketed in 5, 10, and 15-milligram tablets (immediate release and extended release formulations) and has very limited use in the treatment of obesity and attention deficit hyperactivity disorder (ADHD).
Methamphetamine is a chiral compound with two enantiomers, dextromethamphetamine and levomethamphetamine. At room temperature, the free base of methamphetamine is a clear and colorless liquid with an odor characteristic of geranium leaves. It is soluble in diethyl ether and ethanol as well as miscible with chloroform.Dextrorotatory or dextromethamphetamine (also known as d-methamphetamine) is a stronger central nervous system (CNS) stimulant than levomethamphetamine; however, both are considered to be dependence-forming and addictive when misused and capable of producing similar toxicity symptoms at heavy recreational doses.
In contrast, the methamphetamine hydrochloride salt is odorless with a bitter taste. It has a melting point between 170 and 175 °C (338 and 347 °F) and, at room temperature, occurs as white crystals or a white crystalline powder. The hydrochloride salt is also freely soluble in ethanol and water. In a 2013 study of bioreactors in wastewater, methamphetamine was found to be largely degraded within 30 days under exposure to light.
IUPAC name: (RS)-N-methyl-1-phenylpropan-2-amine
Other names: Batu, Bikers Coffee, Black Beauties, Chalk, Chicken,Feed, Crank, Crystal, Glass, Go-Fast, Hiropon, Ice, Meth, Methlies Quick, Poor Man’s Cocaine, Shabu, Shards, Speed, Stove Top, Tina, Trash, Tweak, Uppers, Ventana, Vidrio, Yaba, and Yellow Bam, Desoxyn, Methedrine, N-methylamphetamine, N,α-dimethylphenethylamine, desoxyephedrine;
Racemic methamphetamine may be prepared starting from phenylacetone by either the Leuckart or reductive amination methods. In the Leuckart reaction, one equivalent of phenylacetone is reacted with two equivalents of N-methylformamide to produce the formyl amide of methamphetamine plus carbon dioxide and Methylamine as side products. In this reaction, an iminium cation is formed as an intermediate which is reduced by the second equivalent of N-methylformamide. The intermediate formyl amide is then hydrolyzed under acidic aqueous conditions to yield methamphetamine as the final product.
Also, P2P can be reduced to methamphetamine with help of NaBH4 by following reactions:
Analysis and purification
Methamphetamine is frequently cut by caffeine, nootropics such as Cinnarizine, Piracetam and etc, a-PVP, other Amphetamine-type stimulants and pharmacy substances. There are several methods to check your Amphetamine. The most popular and easiest way is Drugs testing reagents. You can read about other methods in Methmphetamine assessment protocol.
Acid-base extraction (ABE), as a purification method, allows you to get a high-quality drug. Method is useful by reason that it takes available reagents, tools and instruments. Fresh methamphetamine have to be washed by acetone after crystal filtration on a Buchner funnel to clean up them. Also, a final product can be recrystallized with alcohol to obtain large shards of meth. Unfortunately, these methods don’t allow to get rid of caffeine and some pharmaceutical adulterants.
There are pictures of different methamphetamine samples after tests by reagents
Effects and dosage
Subjective effects include motivation enhancement, stamina enhancement, appetite suppression, increased libido, and euphoria. Chronic high-dose use can induce states of anxiety & paranoia, delusions, thought disorganization, psychosis, and violent behavior. It is associated with compulsive redosing, especially when it is vaporized ("smoked") or injected, due to the overwhelming euphoric rush it produces in the user upon initial administration.
Methamphetamine has extremely high abuse and addiction potential; it is widely considered to be one of the most addictive substances due to the intense euphoria it produces. Additionally, unlike Amphetamine at therapeutic doses, methamphetamine at moderate to heavy recreational doses is considered to be directly neurotoxic to humans, damaging both dopamine and serotonin neurons within the central nervous system. In nonhuman mammals, degeneration of monaminergic terminals and neuronal apoptosis (cell death) has been known to occur. In humans the effects are also neurotoxic. It also displays cardiotoxicity, including increased blood pressure and elevated risk of stroke and heart attack.
It is highly advised to use harm reduction practices if using this substance.
Methamphetamine primarily affects the central nervous system (CNS) by acting as a releasing agent for neurotransmitters such as dopamine, norepinephrine, and serotonin. It also acts as a reuptake inhibitor for some transporter neurons, thereby holding neurotransmitters like norepinephrine in the synapse. Meth also acts as reverse transporter for some transporter neurons, increasing levels of monoamines by forcing the neurotransmitters out of their storage vesicles and expelling them into the synaptic gap by making the dopamine transporters work in reverse. Other mechanisms by which methamphetamine are known to increase monoamine levels are by:
In addition to releasing potent amounts of monoamines, MA has a high lipid solubility which leads to a relatively fast transfer of the drug across the blood-brain barrier and a quick onset in comparison to other stimulants. All of this results in feelings of reward, euphoria, and stimulation as well as an unpleasant offset.
Ilegal market data
Methamphetamine continued to dominate seizures and manufacture of Amphetamine-type stimulants at the global level
Data on seizures of ATS (Amphetamine-type stimulants) suggest that, at the global level, global trafficking in ATS continues to be dominated by methamphetamine. Seventy-two per cent of ATS seized over the period 2016–2020 was related to methamphetamine, followed by Amphetamine (17 percent) and “ecstasy” (4 percent), with the remainder being other ATS*.
The number of countries reporting seizures of methamphetamine rose from 84 in the period 2006–2010 to 117 in the period 2016–2020, suggesting a significant increase in the geographical spread of methamphetamine trafficking. The number of countries reporting seizures of Amphetamine and “ecstasy” remained fairly stable between those two periods (91 and 105 countries, and 95 and 103 countries, respectively). Although the total number of countries reporting seizures of ATS has risen, the quantities seized remain somewhat concentrated in certain countries. Three countries accounted for 65 per cent of the global total of methamphetamine seized in the period 2016–2020, three accounted for 54 per cent of “ecstasy” seized, and three accounted for 43 per cent of Amphetamine and “captagon” seized. During the period 2016–2020, nearly 16,000 sites and facilities associated with ATS manufacture were dismantled across 45 countries worldwide. Some 94 percent of them were linked to methamphetamine. The majority (69 percent) of the dismantled sites were involved in the actual manufacture of methamphetamine; the others were waste-dumping sites (19 percent) or warehouses used to store chemicals (11 percent). Facilities involved exclusively in the packaging of methamphetamine accounted for less than 1 percent the total, suggesting that most packaging is still done at manufacturing sites.
The manufacture of all major ATS is affected by trends relating to their various precursors and precursors. Once any such chemical substance not under international control is scheduled, chemists at manufacturing sites explore the use of alternatives. As a result, many manufacturing sites produce not only ATS end products but also the precursors required in the manufacturing process. That tends to give a competitive edge to organized crime groups that have, in loco or can afford to hire from abroad, highly qualified chemists.
*The category “other ATS” includes a number of pharmaceutical stimulants, such as methylphenidate, dexamphetamine, phenmetrazine, and Adderall (a trade name for a combination of racemic Amphetamine and dextroamphetamine), synthetic cathinones under international control (e.g. methcathinone, mephedrone, methylone or 3,4-methylenedioxypyrovalerone (MDPV), originally often marketed as Bath salts) and non-specified ATS.
Our team brings together the best specialists from different fields.
We are ready to share our experience, discuss difficult issues and find new solutions.